Patents by Inventor Mattias Levin

Mattias Levin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDES
    Publication number: 20240117074
    Abstract: The present invention relates to novel bispecific polypeptides, such as antibodies, and their use in the treatment of cancers, particularly cancers expressing carcinoembryonic antigen (CEA).
    Type: Application
    Filed: November 13, 2023
    Publication date: April 11, 2024
    Inventors: PETER ELLMARK, KARIN HAGERBRAND, Laura Varas, Mattias Levin, Anna Säll, Laura von Schantz
  • Peptides
    Patent number: 11873348
    Abstract: The present invention relates to novel bispecific polypeptides, such as antibodies, and their use in the treatment of cancers, particularly cancers expressing carcinoembryonic antigen (CEA).
    Type: Grant
    Filed: November 4, 2022
    Date of Patent: January 16, 2024
    Assignee: ALLIGATOR BIOSCIENCE AB
    Inventors: Peter Ellmark, Karin Hagerbrand, Laura Varas, Mattias Levin, Anna Säll, Laura von Schantz
  • NOVEL PEPTIDES
    Publication number: 20230312754
    Abstract: The present invention relates to novel bispecific polypeptides, such as antibodies, and their use in the treatment of cancers, particularly cancers expressing carcinoembryonic antigen (CEA).
    Type: Application
    Filed: November 4, 2022
    Publication date: October 5, 2023
    Inventors: Peter Ellmark, Karin Hagerbrand, Laura Varas, Mattias Levin, Anna Säll, Laura von Schantz
  • NOVEL POLYPEPTIDES
    Publication number: 20220056148
    Abstract: The present invention provides bispecific antibodies of an antibody format, and which comprise one or more Fab fragments and an immunoglobulin molecule. The invention further provides compositions of said bispecific antibodies, as well as methods and uses of the same. The invention further provides a method of generating bispecific antibodies of the format.
    Type: Application
    Filed: December 17, 2019
    Publication date: February 24, 2022
    Inventors: Anna Sall, Laura Von Schantz, Anneli Nilsson, Barnabas Nyesiga, Jessica Petersson, Mattias Levin
  • Bispecific Polypeptides to GITR and CTLA-4
    Publication number: 20190309084
    Abstract: The present invention provides multispecific polypeptides, such as bispecific antibodies, comprising a first binding domain capable of specifically binding to GITR, and a second binding domain capable of specifically binding to CTLA-4. The invention further provides compositions of said bispecific polypeptides, as well as methods and uses of the same.
    Type: Application
    Filed: November 21, 2017
    Publication date: October 10, 2019
    Inventors: Peter Ellmark, Sara Fritzell, Christina Furebring, Anne Kvarnhammar, Mattias Levin, Per Norlen, Eva Nyblom, Niina Veitonmaki, Magnus Winnerstam